Unlocking Biotech Value: Speed to First-in-Human Matters

Reaching FIH is not only a key scientific milestone, but also a critical driver of value creation and partnership readiness.

Together with Catalent Pharma Services, Consilienta organises a FREE interactive workshop designed to help biotech innovators efficiently navigate CMC, non-clinical, and regulatory challenges on the path to clinical development.

The workshop will bring together experts from across the field to share practical strategies and real-world insights on:

• Rational drug product design in early development and how to avoid delays caused by formulation decisions
• Strategic use of EU regulatory pathways to accelerate drug development
• The role of New Approach Methodologies (NAM) in facilitating FIH
• Technology transfer and CDMO selection strategies

Participants will benefit from an open discussion format and the opportunity for complimentary CMC and multidisciplinary regulatory consultation.

If you would like to learn more about the workshop, please follow the link:
https://www.eventbrite.com/e/unlocking-biotech-value-speed-to-first-in-human-matters-tickets-1990111686627

Registration is open. Participation is free of charge
Unlocking Biotech Value: Speed to First-in-Human Matters Tickets